Get started
Author

Roman Fishchuk

Observed names: R Fishchuk, R. Fishchuk, R. M. Fishchuk, Р. М. Фіщук
ORCID: 0000-0003-4302-2405
Observed ORCID: 0000-0003-4302-2405
OpenAlex ID: A5061037809
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
2020 · W.J. Fokkens, V.J. Lund, et al. · Rhinology Journal · 5,889
PDF
Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19
2021 · José R. Arribas, Sanjay Bhagani, et al. · NEJM Evidence · 124
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15
PDF
Morphological prediction of lethal outcomes in the evaluation of lung tissue structural changes in patients on respiratory support with СOVID-19: Ukrainian experience
2023 · Viktoriya Matskevych, Olexandr Kamyshnyi, et al. · Pathology - Research and Practice · 14
Survey of otolaryngology services in Ukraine and neighbouring Central and Eastern European countries
2017 · M M Verkerk, R Wagner, et al. · The Journal of Laryngology & Otology · 10
Quercetin effectiveness in patients with COVID-19 associated pneumonia
2021 · I. A. Zupanets, О. А. Holubovska, et al. · Zaporozhye Medical Journal · 9
PDF
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
2024 · Tomas O Jensen, Thomas A Murray, et al. · The Lancet Microbe · 6
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4
PDF
The Evolving Frontline of Antimicrobial Resistance: Adapting Testing and Treatment for Austere and Combat Settings
2026 · Kyle C Molina, Corey Bills, et al. · Military Medicine · 2
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT)
2024 · Matthew G. Johnson, Julie M. Strizki, et al. · Microbiology Spectrum · 2
Clinical epidemiology, microbiology, and care of war-related wounds in Ukraine
2026 · Stacy A. Trent, Laurel Beaty, et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 1
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial
2026 · Jason V Baker, Lianne K Siegel, et al. · Clinical Infectious Diseases · 1
The Results of the Clinical Study: an Open-label Multicenter Randomized Trial to Evaluate the Efficacy of Bioven, Manufactured by Biopharma Plasma, Llc, in Complex Therapy of Patients With Pneumonia Induced by Covid-19/sars-cov-2
2020 · А. Р. Рибаков, Я. Г. Жебеленко, et al. · Pain anesthesia and intensive care · 1
PDF
Design and implementation of an international multiarm, multistage master protocol for trials of complex traumatic wound care during active war in Ukraine
2026 · Corey B. Bills, Camille J. Hochheimer, et al. · The Journal of Trauma: Injury, Infection, and Critical Care
Treatment of Serous Otitis Media
2017 · D. T. Orishchak, N. V. Vasyliuk, et al. · Archive of Clinical Medicine
PDF
Works count: 17
Citation count: 6,165
H-index: 8
I10-index: 6
Year
Topic
Type